Scribe Therapeutics, Inc. (SCTX)
16.00
+0.52
(+3.36%)
USD |
NASDAQ |
Nov 06, 10:21
Scribe Therapeutics Net Income (Quarterly) : -6.477M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -6.477M |
| March 31, 2026 | -17.35M |
| Date | Value |
|---|---|
| June 30, 2025 | -9.903M |
| March 31, 2025 | -3.425M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Ionis Pharmaceuticals, Inc. | -114.65M |
| Twist Bioscience Corp. | -35.05M |
| Veracyte, Inc. | 31.50M |
| Cypherpunk Technologies, Inc. | 39.39M |
| Nurix Therapeutics, Inc. | 549.81M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 1.918M |
| Total Expenses (Quarterly) | 8.395M |
| EPS Diluted (Quarterly) | -0.3421 |
| Enterprise Value | 413.68M |
| Gross Profit Margin (Quarterly) | 59.07% |
| Profit Margin (Quarterly) | -337.7% |
| Earnings Yield | -12.79% |
| Normalized Earnings Yield | -12.85 |